Spero Therapeutics
SPRO
#9124
Rank
NZ$0.11 B
Marketcap
$2.04
Share price
-0.83%
Change (1 day)
1.92%
Change (1 year)

Spero Therapeutics (SPRO) - Cash on Hand

Cash on Hand as of June 2024 : NZ$0.10 Billion

According to Spero Therapeutics's latest financial reports the company has NZ$0.10 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Spero Therapeutics - Cash on Hand chart (from 2016 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.12 B-29.76%
2022-12-31NZ$0.17 B-19.82%
2021-12-31NZ$0.21 B21.86%
2020-12-31NZ$0.17 B44.38%
2019-12-31NZ$0.12 B-29.22%
2018-12-31NZ$0.17 B40.03%
2017-12-31NZ$0.12 B725.36%
2016-12-31NZ$14.89 M79.09%
2015-12-31NZ$8.31 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$62.6 M-42.43%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$23.45 B 21,468.78%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.05 B 2,709.83%๐Ÿ‡จ๐Ÿ‡ฆ Canada